USA flag logo/image

An Official Website of the United States Government

ANTI HIV-1 ACTIVITY OF TRIPLEX FORMING OLIGNUCLEOTIDES

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
18968
Program Year/Program:
1992 / SBIR
Agency Tracking Number:
18968
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Triplex Pharmaceutical
9391 Grogans Mill Road The Woodlands, TX 77380
View profile »
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1992
Title: ANTI HIV-1 ACTIVITY OF TRIPLEX FORMING OLIGNUCLEOTIDES
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

ANTIVIRAL AGENTS FOR THE TREATMENT FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) ARE DEARLY IN GREAT NEED. WE HAVE SYNTHESIZED AND DONE PRELIMINARY EXPERIMENTS WITH A TRIPLE HELIX FORMING OLIGONUCLEOTIDE DESIGNED TO BIND TO CRITICAL REGULATORY REGIONS IN THE PROVIRAL GENOME OF HIV-1. PRELIMINARY DATA SHOW THAT COMPOUND INHIBITS VIRAL P24 PRODUCTION IN A CHRONICALLY INFECTED MONOCYTE CELL LINE. THE PRIMARY GOAL DURING THE PHASE I FUNDING PERIOD WILL BE TO VALIDATE THE EFFICACY OF THIS COMPOUND IN PREPARATION FOR IN VIVO PHARMACOLOGICAL TESTING DURING PHASE II. VALIDATION WILL FOCUS ON DEMONSTRATING THE MECHANISM OF ACTION OF THE COMPOUND AND EXAMINING THE RANGE OF IN VITRO SYSTEMS IN WHICH THE COMPOUND IS ACTIVE. A SECONDARY GOAL WILL BE TO IMPROVE THE PERFORMANCE OF THE COMPOUND BY SELECTED STRUCTURAL MODIFICATIONS DESIGNED TO INCREASE AFFINITY AND CELLULAR UPTAKE. MODIFIED AND UNMODIFIED COMPOUNDS WILL BE TESTED FOR IMPROVEMENT IN BINDING AFFINITY, CELLULAR UPTAKE, INHIBITION OF IN VITRO TRANSCRIPTION AND EFFICACY IN SEVERAL CHRONICALLY INFECTED AND ACUTELY INFECTED CELL SYSTEMS TO DETERMINT THEFT RANGE OF ACTIVITY.

Principal Investigator:

Joseph G Zendegui
7133638761

Business Contact:

Small Business Information at Submission:

Triplex Pharmaceutical
9391 Grogran's Mill Road The Woodlands, TX 77380

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No